Clinical Pathology expert witnesses

Laboratory data drives a significant share of clinical decision-making, yet the personnel who generate, validate, and report that data rarely appear on witness lists without deliberate effort by counsel. Clinical pathologists are the physicians responsible for the integrity of that pipeline — from specimen collection standards through instrument quality control to result reporting and critical-value notification. When something in that pipeline fails and a patient is harmed, a clinical pathology expert can map the failure to a specific process, a specific person, or a specific deviation from published laboratory standards.

For plaintiffs, this testimony establishes that a defendant laboratory or institution fell below the standard of care applicable to laboratory operations, that the deviation caused a foreseeable harm, and that the harm would not have occurred had accepted protocols been followed. For defendants, a clinical pathology expert can demonstrate that laboratory operations were conducted within regulatory and professional standards, that an alleged error did not meet the threshold of clinical significance, or that the outcome was attributable to factors outside the laboratory's control. In either posture, the expert's value is greatest when retained early enough to shape record requests, deposition outlines, and the framing of technical issues for a non-specialist jury.

The cases that most frequently draw on clinical pathology expertise share a common feature: the disputed conduct is documentary and process-based rather than purely clinical. Delayed sepsis diagnosis cases often involve laboratory turnaround times, critical-value notification logs, and blood culture protocols. Transfusion reaction cases turn on blood bank procedures, compatibility testing, and post-transfusion documentation. Coagulation-related injury cases — bleeding events during anticoagulation therapy, for example — require interpretation of serial laboratory values and the adequacy of monitoring intervals.

Misdiagnosis matters involving cancer frequently implicate both anatomic and clinical pathology, particularly when a hematologic malignancy was suggested by a peripheral blood smear or bone marrow evaluation that was either not performed or not acted upon. Medication toxicity cases involving drugs with narrow therapeutic windows depend on whether serum drug levels were drawn, reported, and communicated within acceptable timeframes. Workplace exposure and toxic-tort matters sometimes require a clinical pathologist to interpret biomarker panels, heavy-metal screens, or occupational exposure indicators. Newborn screening failures and neonatal jaundice cases involving bilirubin monitoring are another recurring category. Across all of these, the clinical pathology expert provides the technical vocabulary that translates laboratory documentation into legally actionable findings.

Every clinical pathology expert listed in this directory goes through a structured verification process before their profile is published. The first step is confirmation of graduate medical education and completion of an accredited pathology residency. The second step is verification of current or lapsed board certification status with the American Board of Pathology, including the specific certificate held — clinical pathology, hematology, blood banking/transfusion medicine, clinical informatics, or others — because the precise certification matters when matching an expert to a case's laboratory issue.

Active state medical licensure is checked against the relevant state board database, and the profile notes the jurisdictions in which the expert is licensed to practice. Publicly available disciplinary records, Medicare and Medicaid exclusion lists, and National Practitioner Data Bank disclosures that are accessible through public channels are reviewed as part of intake. Experts are asked to provide a current CV and, where applicable, a list of prior testimony engagements. Profiles are subject to periodic re-review, and attorneys who identify a discrepancy are encouraged to report it so the listing can be audited promptly.

A clinical pathology engagement typically begins with a records review phase during which the expert examines laboratory reports, instrument logs, quality control records, critical-value notification documentation, and relevant sections of the medical record. This phase produces a written or verbal preliminary opinion on whether the laboratory conduct at issue met or deviated from the applicable standard of care. The expert will also assess causation — specifically, whether a laboratory deviation was a proximate contributing factor to the claimed harm or whether the outcome would have been the same regardless of the alleged error.

If the matter proceeds, the expert may prepare a written report meeting the disclosure requirements of the applicable procedural rules, provide deposition testimony, review and respond to opposing expert reports, and testify at trial. Clinical pathology experts with active laboratory directorship experience are generally accustomed to explaining technical concepts in accessible terms, since they routinely communicate with clinical staff who are not laboratory specialists. When selecting an expert, consider whether the case requires someone who has testified before — deposition transcripts and prior testimony disclosures, where available, are included in the directory's CV packages to help you evaluate that dimension. Fee structures, availability, and jurisdictional practice history should be confirmed directly with the expert before retaining.

Clinical pathology testimony rests on a foundation of published laboratory standards, accreditation requirements, and instrument validation data that generally satisfies the methodology and reliability inquiries courts conduct under Daubert and FRE 702. The College of American Pathologists, the Clinical and Laboratory Standards Institute, and CLIA regulations provide objective benchmarks against which laboratory conduct can be measured — a significant evidentiary advantage compared with disciplines where the standard of care is more diffuse or contested.

Challenges to clinical pathology opinions most often target the qualifications prong — particularly when the opposing party argues that the expert's training does not map precisely onto the laboratory discipline at issue — or the application-to-facts prong, where the challenge is that the expert's general methodology was not reliably applied to the specific facts of the case. Retaining an expert whose board certification and practice history align closely with the laboratory function in dispute reduces exposure on the qualifications prong. Ensuring that the expert's report draws explicit connections between the documented laboratory deviation and the published standard it violated reduces exposure on the methodology prong. Experts listed in this directory are matched to matters based on subspecialty fit, not just general pathology credentials, to support admissibility from the outset.